Approvals/NMPA/Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (I)

Approved

化学药品

Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (I)

浙江东亚药业股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8mvZ6slcq2y
Approval Number: 国药准字H20263529
Generic Name: 沙格列汀二甲双胍缓释片(Ⅰ)
Generic Name En: Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (I)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含沙格列汀5mg和盐酸二甲双胍1000mg
Reg Date: 2026-03-10
Company Name: 浙江东亚药业股份有限公司
Company Address: 浙江省三门县浦坝港镇沿海工业城
Production Company Name: 宁波双成药业有限公司
Production Company Address: 浙江省宁波市杭州湾新区滨海四路866号
Company Detail Path: /organization/zhejiang-east-asia-pharmaceutical-co-ltd
Production Company Detail Path: /organization/zhu-bo-shuang-cheng-yao-ye-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 10, 2026

Approval ID

8mvZ6slcq2y

Type

化学药品